These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8095062)

  • 1. Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis.
    Furukawa S; Matsubara T; Obara T; Okumura K; Yabuta K
    J Infect Dis; 1993 Mar; 167(3):778-9. PubMed ID: 8095062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum soluble CD2, CD4 and CD8 levels in infectious mononucleosis].
    Motohashi T
    Arerugi; 1993 Aug; 42(8):926-33. PubMed ID: 7902699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Kawasaki disease and infectious mononucleosis in terms of natural killer cell and CD8+ T cell subsets.
    Furukawa S; Matsubara T; Tsuji K; Motohashi T; Watanabe T; Umezawa Y; Yabuta K
    J Infect Dis; 1991 Feb; 163(2):416-7. PubMed ID: 1824854
    [No Abstract]   [Full Text] [Related]  

  • 4. The pattern of activation antigen expression on T-lymphocyte subpopulation in infectious mononucleosis.
    Pálóczi K; Pócsik E; Kotlán B; Ujhelyi E; Timár L; Petrányi GG
    Haematologia (Budap); 1991; 24(2):83-90. PubMed ID: 1840056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of activation markers on tonsillar T lymphocytes.
    Plum J; Van Cauwenberge P; De Smedt M
    Acta Otolaryngol Suppl; 1988; 454():113-7. PubMed ID: 2906200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte anergy during acute infectious mononucleosis is restricted to the clonotypic receptor activation pathway.
    Pérez-Blas M; Regueiro JR; Ruiz-Contreras JR; Arnaiz-Villena A
    Clin Exp Immunol; 1992 Jul; 89(1):83-8. PubMed ID: 1628427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of LFA-1 and ICAM-1 on peripheral blood T-cells and soluble CD2 levels in serum during acute Kawasaki disease].
    Tsuji K
    Arerugi; 1993 Apr; 42(4):564-70. PubMed ID: 8323454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis.
    Rowley AH; Baker SC; Kim KA; Shulman ST; Yang A; Arrollo D; DeBerge M; Han S; Sibinga NES; Pink AJ; Thorp EB
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e94-e102. PubMed ID: 28505365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CD2-/CD3+ T cells in fetal human tissue.
    Kabelitz D; Conradt P
    J Exp Med; 1988 Nov; 168(5):1941-6. PubMed ID: 2903216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RPA-2.10: an anti-CD2 monoclonal antibody that inhibits alloimmune responses and monitors T cell activation.
    Aversa GG; Bishop GA; Suranyi MG; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):277-8. PubMed ID: 2908548
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term observation in patients with Kawasaki syndrome and their relation to Epstein-Barr virus infection.
    Okano M; Hase N; Sakiyama Y; Matsumoto S
    Pediatr Infect Dis J; 1990 Feb; 9(2):139-41. PubMed ID: 2156214
    [No Abstract]   [Full Text] [Related]  

  • 12. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice.
    Budd RC; Russell JQ; van Houten N; Cooper SM; Yagita H; Wolfe J
    J Immunol; 1992 Feb; 148(4):1055-64. PubMed ID: 1346621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells.
    Yagita H; Nakamura T; Karasuyama H; Okumura K
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):645-9. PubMed ID: 2463634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxicity of poly-drug use: abnormalities in the active and high-affinity CD2 antigen (E-rosette receptor) bearing T-lymphocytes.
    Nair BS; Erickson JR; Pillai R; Estrada A; Watson RR
    Toxicol Lett; 1991 Aug; 57(3):339-45. PubMed ID: 1679260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukocyte adhesion molecules and their clinical significance].
    Hurme M; Jalkanen S; Vakkila J
    Duodecim; 1988; 104(19):1507-14. PubMed ID: 2903823
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte subpopulations in Kawasaki disease.
    Shannon K; Fink CW; Buchanan GR; Punaro M; Stastny P
    Clin Exp Rheumatol; 1983; 1(1):59-62. PubMed ID: 6398155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.
    Matsubara T; Furukawa S; Motohashi T; Okumura K; Yabuta K
    Eur J Pediatr; 1995 Oct; 154(10):826-9. PubMed ID: 8529682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia.
    Maslak P; Miller WH; Heller G; Scheinberg DA; Dmitrovsky E; Warrell RP
    Blood; 1993 Mar; 81(6):1666. PubMed ID: 8095829
    [No Abstract]   [Full Text] [Related]  

  • 19. CD2 can mediate TCR/CD3-independent T cell activation.
    Ohno H; Ushiyama C; Taniguchi M; Germain RN; Saito T
    J Immunol; 1991 Jun; 146(11):3742-6. PubMed ID: 1674520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of alteration in lymphocyte subsets among varicella, hand-foot-and-mouth disease, scarlet fever, measles, and Kawasaki disease.
    Yanase Y; Tango T; Okumura K; Tada T; Kawasaki T
    Microbiol Immunol; 1987; 31(7):701-10. PubMed ID: 3501823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.